Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   The D2 and D3 sublineages of human papillomavirus 16-positive cervical cancer in Guatemala differ in integration rate and age of diagnosis
  2. Lou,Hong; Boland,Joseph; Torres-Gonzalez, Edmundo; Albanez, Anaseidy; Zhou,Weiyin; Steinberg,Mia; Diaw, Lena; Mitchell, Jason; Roberson, David; Cullen,Michael; Garland,Lisa; Bass,Sara; Burk, Robert D; Yeager,Meredith; Wentzensen, Nicolas; Schiffman, Mark; Alvirez Freites, Enrique; Gharzouzi, Eduardo; Mirabello, Lisa; Dean, Michael
  3. Cancer research. 2020, SEP 15; 80(18): 3803-3809.
  1. 2.   Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance
  2. Zhu, Bin; Xiao, Yanzi; Yeager,Meredith; Clifford, Gary; Wentzensen, Nicolas; Cullen,Michael; Boland,Joseph; Bass,Sara; Steinberg,Mia; Raine-Bennett, Tina; Lee, DongHyuk; Burk, Robert D; Pinheiro, Maisa; Song,Lei; Dean, Michael; Nelson, Chase W; Burdett,Laurie; Yu, Kai; Roberson, David; Lorey, Thomas; Franceschi, Silvia; Castle, Philip E; Walker, Joan; Zuna, Rosemary; Schiffman, Mark; Mirabello, Lisa
  3. Nature communications. 2020, Feb 14; 11(1): pii: 10.1038/s41467-020-14730-1.
  1. 3.   TLR-based immune adjuvants
  2. Steinhagen, F.; Kinjo, T.; Bode, C.; Klinman, D. M.
  3. Vaccine. 2011, Apr; 29(17): 3341-3355.
  1. 4.   Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine
  2. Dauner, J. G.; Pan, Y. J.; Hildesheim, A.; Harro, C.; Pinto, L. A.
  3. Vaccine. 2010, Jul; 28(33): 5407-5413.
  1. 5.   Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Dodd, L.; Kemp, T. J.; Yang, J.; Fullmer, B.; Harro, C.; Lowy, D. R.; Lempicki, R. A.; Pinto, L. A.
  3. Journal of Immunology. 2009 182(3): 1706-1729.
  1. 6.   Determinants and Correlation of Systemic and Cervical Concentrations of Total IgA and IgG
  2. Safaeian, M.; Kemp, T.; Falk, R. T.; Rodriguez, A. C.; Hildesheim, A.; Williams, M.; Porras, C.; Herrero, R.; Pinto, L. A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(10): 2672-2676.
  1. 7.   Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan
  2. Roberts, J. N.; Buck, C. B.; Thompson, C. D.; Kines, R.; Bernardo, M.; Choyke, P. L.; Lowy, D. R.; Schiller, J. T.
  3. Nature Medicine. 2007, Jul; 13(7): 857-861.
  1. 8.   E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells
  2. Mani, A.; Oh, A. S.; Bowden, E. T.; Lahusen, T.; Lorick, K. L.; Weissman, A. M.; Schlegel, R.; Wellstein, A.; Riegel, A. T.
  3. Cancer Research. 2006, Sep; 66(17): 8680-8686.
  1. 9.   Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles
  2. Pinto, L. A.; Viscidi, R.; Harro, C. D.; Kemp, T. J.; Garcia-Pineres, A. J.; Trivett, M.; Demuth, F.; Lowy, D. R.; Schiller, J. T.; Berzofsky, J. A.; Hildesheim, A.
  3. Virology. 2006, Sep; 353(2): 451-462.
  1. 10.   Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Trivett, M.; Williams, M.; Wu, L.; KewalRamani, V. N.; Pinto, L. A.
  3. European Journal of Immunology. 2006, Feb; 36(2): 437-445.
  1. 11.   Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies
  2. Wang, S. S.; Hildesheim, A.; Gao, X. J.; Schiffman, M.; Herrero, R.; Bratti, M. C.; Sherman, M. E.; Barnes, W. A.; Greenberg, M. D.; McGowan, L.; Mortel, R.; Schwartz, P. E.; Zaino, R. J.; Glass, A. G.; Burk, R. D.; Karacki, P.; Carrington, M.
  3. Journal of Infectious Diseases. 2002 186(5): 598-605.
  1. 12.   Human papillomavirus and cancer: The viral transforming genes
  2. Phillips, A. C.; Vousden, K. H.; Newton, R.; Beral, V.; Weiss, R. A.
  3. Infections and Human Cancer. 1999; 33 : 55-74.
  1. 13.   Reversal of p53-induced cell-cycle arrest
  2. Bates, S.; Hickman, E. S.; Vousden, K. H.
  3. Molecular Carcinogenesis. 1999 24(1): 7-14.
  1. 14.   HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates
  2. Strickler, H. D.; Kirk, G. D.; Figueroa, J. P.; Ward, E.; Braithwaite, A. R.; Escoffery, C.; Drummond, J.; Goebel, B.; Waters, D.; McClimens, R.; Manns, A.
  3. International Journal of Cancer. 1999 80(3): 339-344.
  1. 15.   Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion
  2. Young, M. R.; Li, J. J.; Rincon, M.; Flavell, R. A.; Sathyanarayana, B. K.; Hunziker, R.; Colburn, N.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(17): 9827-9832.
  1. 16.   Regulation and activation of p53 and its family members
  2. Lohrum, M. A. E.; Vousden, K. H.
  3. Cell Death and Differentiation. 1999 6(12): 1162-1168.
  1. 17.   A Human Vascular Endothelial Cell Model to Study Angiogenesis and Tumorigenesis
  2. Rhim, J. S.; Tsai, W. P.; Chen, Z. Q.; Chen, Z.; Vanwaes, C.; Burger, A. M.; Lautenberger, J. A.
  3. Carcinogenesis. 1998 19(4): 673-681.
  1. 18.   Human Leukocyte Antigen Class I/Ii Alleles and Development of Human Papillomavirus-Related Cervical Neoplasia - Results From a Case-Control Study Conducted in the United States
  2. Hildesheim, A.; Schiffman, M.; Scott, D. R.; Marti, D.; Kissner, T.; Sherman, M. E.; Glass, A. G.; Manos, M. M.; Lorincz, A. T.; Kurman, R. J.; Buckl, J.; Rush, B. B.; Carrington, M.
  3. Cancer Epidemiology Biomarkers & Prevention. 1998 7(11): 1035-1041.
  1. 19.   Expression of Dominant Negative Jun Inhibits Elevated Ap-1 and Nf-Kappa-B Transactivation and Suppresses Anchorage Independent Growth of Hpv Immortalized Human Keratinocytes
  2. Li, J. J.; Rhim, J. S.; Schlegel, R.; Vousden, K. H.; Colburn, N. H.
  3. Oncogene. 1998 16(21): 2711-2721.
  1. 20.   Proteolytic Cleavage of Human P53 By Calpain - a Potential Regulator of Protein Stability
  2. Kubbutat, M. H. G.; Vousden, K. H.
  3. Molecular and Cellular Biology. 1997 17(1): 460-468.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel